Elaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes

FEMS Immunology and Medical Microbiology

Volumn 65, Issue 2, 2012, Pages 257-269

  Gharbi, Aïcha ^a   Humblot, Vincent ^b   Turpin, Frédéric ^a   Pradier, Claire Marie ^b   Imbert, Christine ^a   Berjeaud, Jean Marc ^a  

^a IBMIG Institut de Biologie Moleculaire et dIngenierie Genetique   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

Anidulafungin; Antibiofilm material; Candida albicans; Cyclodextrins; Thymol

Indexed keywords

ALPHA CYCLODEXTRIN; ANIDULAFUNGIN; BETA CYCLODEXTRIN; ECHINOCANDIN; THYMOL;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL DENSITY; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ESTERIFICATION; FLUORESCENCE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SOLUBILIZATION; YEAST;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CYCLODEXTRINS; ECHINOCANDINS; FLUORESCENT DYES; GOLD; HUMANS; MICROSCOPY, CONFOCAL; STAINING AND LABELING; SURFACE PROPERTIES; THYMOL;

EID: 84862666822     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.00932.x     Document Type: Article

References (56)

1. Bain CD, Troughton EB, Tao YT, Evall J, Whitesides GM & Nuzzo RG (1989) Formation of monolayer films by the spontaneous assembly of organic thiols from solution onto gold. J Am Chem Soc 111: 321-325.
2. Beer AM, Lukanov J & Sagorchev P (2007) Effect of Thymol on the spontaneous contractile activity of the smooth muscles. Phytomedicine 14: 65-69.
3. Bertilsson L & Liedberg B (1993) Infrared study of thiol monolayer assemblies on gold: preparation, characterization, and functionalization of mixed monolayers. Langmuir 9: 141-149.
4. Blanchemain N, Karrout Y, Tabary N, Neut C, Bria M, Siepmann J, Hildebrand HF & Martel B (2011) Methyl-beta-cyclodextrin modified vascular prosthesis: influence of the modification level on the drug delivery properties in different media. Acta Biomater 7: 304-314.
5. Braga PC, Culici M, Alfieri M & Dal Sasso M (2008) Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents 31: 472-477.
6. Briand E, Salmain M, Compere C & Pradier CM (2006a) Immobilization of Protein A on SAMs for the elaboration of immunosensors. Colloids Surf B Biointerfaces 53: 215-224.
7. Briand E, Salmain M, Herry JM, Perrot H, Compere C & Pradier CM (2006b) Building of an immunosensor: how can the composition and structure of the thiol attachment layer affect the immunosensor efficiency? Biosens Bioelectron 22: 440-448.
8. Burt S (2004) Essential oils: their antibacterial properties and potential applications in foods - a review. Int J Food Microbiol 94: 223-253.
9. Cateau E, Berjeaud JM, Rodier MH & Imbert C (2008) Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm. Int J Antimicrob Agents 31: 166-170.
10. Cateau E, Berjeaud JM & Imbert C (2011) Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone. Int J Antimicrob Agents 37: 380-384.
11. Chiou CC, Groll AH & Walsh TJ (2000) New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 5: 120-135.
12. Cocuaud C, Rodier MH, Daniault G & Imbert C (2005) Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56: 507-512.
13. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
14. Curtin J, Cormican M, Fleming G, Keelehan J & Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47: 3145-3148.
15. Dalleau S, Cateau E, Berges T, Berjeaud JM & Imbert C (2008) In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents 31: 572-576.
16. Danese PN (2002) Antibiofilm approaches: prevention of catheter colonization. Chem Biol 9: 873-880.
17. Demian BA (2000) Correlation of the solubility of several aromatics and terpenes in aqueous hydroxypropyl-beta-cyclodextrin with steric and hydrophobicity parameters. Carbohydr Res 328: 635-639.
18. Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C & Kaplan JB (2007) Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51: 2733-2740.
19. Dorman HJ & Deans SG (2000) Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88: 308-316.
20. Dwyer A (2008) Surface-treated catheters - a review. Semin Dial 21: 542-546.
21. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN & Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244.
22. Enoch DA, Ludlam HA & Brown NM (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55: 809-818.
23. Frömming KH & Szejtli J (1994) Cyclodextrins in Pharmacy. Kluwer Academic Publications, Dordrecht.
24. Fujiwara T, Tanaka N & Kobayashi S (1990) Structure of δ-Cyclodextrin 13.75H2O. Chem Lett 19: 739-742.
25. Hashimoto H (1991) Preparation, structure, property and application of branched cyclodextrins. New Trends in Cyclodextrins and Derivatives (Duchene D, ed.), pp. 97-156. Edition de Santé, Paris.
26. Humblot V, Yala JF, Thebault P, Boukerma K, Hequet A, Berjeaud JM & Pradier CM (2009) The antibacterial activity of Magainin I immobilized onto mixed thiols Self-Assembled Monolayers. Biomaterials 30: 3503-3512.
27. Imbert C, Rodier MH, Daniault G & Jacquemin JL (2002) Influence of sub-inhibitory concentrations of conventional antifungals on metabolism of Candida albicans and on its adherence to polystyrene and extracellular matrix proteins. Med Mycol 40: 123-129.
28. Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C & Roilides E (2008) Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 52: 357-360.
29. Kite P, Eastwood K, Sugden S & Percival SL (2004) Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42: 3073-3076.
30. Kuhn DM, George T, Chandra J, Mukherjee PK & Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773-1780.
31. Lewis K & Klibanov AM (2005) Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol 23: 343-348.
32. Lopez P, Sanchez C, Batlle R & Nerin C (2007) Vapor-phase activities of cinnamon, thyme, and oregano essential oils and key constituents against foodborne microorganisms. J Agric Food Chem 55: 4348-4356.
33. Mah TF & O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
34. Mansouri MD & Darouiche RO (2008) In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens. Clin Microbiol Infect 14: 190-192.
35. Melton LD & Slessor KN (1971) Synthesis of monosubstituted cyclohexaamyloses. Carbohydr Res 18: 29-37.
36. Messer SA, Moet GJ, Kirby JT & Jones RN (2009) Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J Clin Microbiol 47: 1942-1946.
37. Miyazawa I, Ueda H, Nagase H, Endo T, Kobayashi S & Nagai T (1995) Physicochemical properties and inclusion complex formation of δ-cyclodextrin. Eur J Pharm Sci 3: 153-162.
38. 1H-NMR NOE and molecular modelling to characterize thymol and carvacrol β-cyclodextrin complexes. Int J Pharm 128: 81-88.
39. Nava-Ortiz CA, Burillo G, Concheiro A, Bucio E, Matthijs N, Nelis H, Coenye T & Alvarez-Lorenzo C (2010) Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro. Acta Biomater 6: 1398-1404.
40. Nostro A, Marino A, Blanco AR, Cellini L, Di Giulio M, Pizzimenti F, Sudano Roccaro A & Bisignano G (2009) In vitro activity of carvacrol against staphylococcal preformed biofilm by liquid and vapour contact. J Med Microbiol 58: 791-797.
41. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ & Donlan RM (2005) Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26: 515-519.
42. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J & Diekema DJ (2010) Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol 48: 52-56.
43. Pitha J, Milecki J, Fales H, Pannell L & Uekama K (1987) Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. Int J Pharm 29: 73-82.
44. Ponce-Cevallos PA, Buera MD & Elizalde BE (2010) Encapsulation of cinnamon and thyme essential oils components (cinnamaldehyde and thymol) in β-cyclodextrin: effect of interactions with water on complex stability. J Food Eng 99: 70-75.
45. Raad II& Hanna HA (2002) Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162: 871-878.
46. Raad I, Hanna H & Maki D (2007) Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7: 645-657.
47. Schierholz JM & Beuth J (2001) Implant infections: a haven for opportunistic bacteria. J Hosp Infect 49: 87-93.
48. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S & Ghannoum MA (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48: 1727-1732.
49. Seidler M, Salvenmoser S & Muller FM (2006) In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 28: 568-573.
50. Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R & Mermel LA (2002) Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46: 1674-1679.
51. Tielens F, Costa D, Humblot V & Pradier CM (2008) Characterization of w-functionalized undecanethiol mixed self-assembled monolayers on Au(111): a combined polarization modulation infrared reflection-absorption spectroscopy/X-ray photoelectron spectroscopy/periodic density functional theory study. J Phys Chem C 112: 182-190.
52. Tiller JC, Liao CJ, Lewis K & Klibanov AM (2001) Designing surfaces that kill bacteria on contact. P Natl Acad Sci USA 98: 5981-5985.
53. von Eiff C, Jansen B, Kohnen W & Becker K (2005) Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65: 179-214.
54. Xu J, Zhou F, Ji BP, Pei RS & Xu N (2008) The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol 47: 174-179.
55. Yala JF, Thebault P, Hequet A, Humblot V, Pradier CM & Berjeaud JM (2011) Elaboration of antibiofilm materials by chemical grafting of an antimicrobial peptide. Appl Microbiol Biotechnol 89: 623-634.
56. Zhong N, Byun HS & Bittman R (1998) An improved synthesis of 6-O-monotosyl-6-deoxy-β-cyclodextrin. Tetrahedron Lett 39: 2919-2920.